Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis (CASPHYLAX)
This study is currently recruiting participants.
Verified July 2011 by Wuerzburg University Hospital
Study NCT01318148   Information provided by Wuerzburg University Hospital

First Received on March 17, 2011.   Last Updated on July 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fungal Infection
Additional conditions recognized in this trial
Mycoses
Interventions listed in this trial
caspofungin
Additional drug interventions recognized in this trial
Antifungal Agents
Clotrimazole
Echinocandins
Miconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Anti-Infective Agents, Local
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Wuerzburg University Hospital
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services